维普中文期刊产品整合服务
14篇 您的检索式:作者名="Carl Nathan"
    题名 作者 年代 出处 被引量
1Chimeric Antigen Receptor Therapy for Cancer显示文摘David M. Barrett Nathan Singh David L. Porter Stephan A. Grupp Carl H. June 2014Annual Review of Medicine2014,,:3
2Nonresolving Inflammation显示文摘Carl Nathan Aihao Ding 2010Cell2010,,6:2
3Points of Control in Inflammation显示文摘Nathan Carl 2002Nature2002,420,:1
4Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase显示文摘CARL NATHAN NOEL CALINGASAN JON NEZEZON 2005The Journal of Experimental Medicine2005,202,9:1
5Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling 显示文摘Carl Nathan 2003J Clin Invest2003,111,:1
6Points of control in inflammation显示文摘Carl Nathan 2002Nature2002,420,:1
7Oxygen and the inflammatory显示文摘Carl Nathan 2003Nature2003,422,6933:1
8Portal vein thrombosis in liver transplantation: radiologic evaluation, risk factors, and occult diagnosis显示文摘Aim:Portal vein thrombosis(PVT)in the liver transplant recipient poses many challenges.Unfortunately,the risk factors and effects on outcomes of PVT are not well-defined.Methods:This study analyzed the experience with PVT in liver transplant program from 2007 to 2013.This included the effectiveness of PVT diagnostics and its risk factors using logistical regression.The primary endpoints were Kaplan-Meir patient and graft survival.The secondary endpoints were the length of stay(LOS),transfusion rate,and overall morbidity.Independent predictors of survival were identified using a Cox’s proportional hazards model.Results:Two hundred and sixteen consecutive liver transplant recipients were examined,and 30(13.8%)had either a total or partial PVT.Two hundred and five patients had imaging within 1 year of liver transplantation with only 7(23.3%)of the 30 PVTs identified pre-operatively.Calculated sensitivity(4.8-50%)and negative predictive values(10.5-22.2%)were poor.Only,age significantly predicted PVT[P=0.037/hazard ratio(HR)=0.95].Ninety-day-patient and graft survival for PVT was similar at 6 months,although 1-year survival was significantly lower.“Occult”PVT was not associated with inferior survival.Model for end-stage liver disease score>25(P=0.001,HR=0.49/P=0.004,HR=0.52)and age>60 years(P=0.017,HR=0.64/P=0.013,HR=0.67)were significant predictors of patient and graft survival.Although the transfusion rate was significantly greater with PVT,LOS,and morbidity were not.Conclusion:Older recipients had a greater likelihood of PVT.Diagnostic studies were not effective at excluding PVT,and occult diagnosis did not affect the outcome.PVT was not an independent predictor of mortality or graft loss,but was associated with greater blood loss but not increased LOS or morbidity.Adam Hauch Carl Winkler Eric Katz Peter W.Lundberg Mary Killackey Anil S.Paramesh Luis A.Balart Nathan J.Shores Martin Moehlen Ward Miller Douglas P.Slakey Joseph F.Buell Bob H.Saggi 2016Hepatoma Research2016,2,1:1
9Nonresolving Inflammation显示文摘Carl Nathan Aihao Ding 2010Cell2010,140,6:1
10Exaggerated Left Ventricular Dilation and Reduced Collagen Deposition After Myocardial Infarction in Mice Lacking Osteopontin显示文摘Nathan A. Trueblood Zhonglin Xie Catherine Communal Flora Sam Soeun Ngoy Lucy Liaw Alan W. Jenkins Jing Wang Douglas B. Sawyer Oscar H.L. Bing Carl S. Apstein Wilson S. Colucci Krishna Singh 2001Circulation Research: Journal of the American Heart Association2001,,10:1
11Regulation of biosynthesis of nitric oxide显示文摘Carl Nathan OV Xue QW 1994J Bio Chem1994,269,13:1
12nitric oxide synthases: roles, tolls and controls 显示文摘Carl Nathan 1994Cell1994,78,:1
13Five-coloring graphs on the Klein bottle显示文摘Nathan Chenette Luke Postle Noah Streib Robin Thomas Carl Yerger 2012Journal of Combinatorial Theory Series B2012,,5:1
14Chimeric Antigen Receptor Therapy for Cancer显示文摘David M. Barrett Nathan Singh David L. Porter Stephan A. Grupp Carl H. June 2014Annual Review of Medicine2014,,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费